Winway Health Desk
Pfizer’s COVID vaccine data raise some flags, analysts say, but not...
When the FDA released a 53-page briefing document on Pfizer’s COVID-19 mRNA vaccine candidate yesterday, most readers zeroed in on the shot’s high efficacy...
CMS’ new Geo care delivery model: 5 things to know
The Centers for Medicare & Medicaid Services has introduced a new voluntary payment and care delivery model that will test a regional approach to...
AbbVie’s arthritis hotshot Rinvoq grabs a win in ulcerative colitis
AbbVie’s next-gen immunology med Rinvoq has been turning heads with its rheumatoid arthritis launch, but it was never meant to stop there. While attention...
3 tech-driven innovative patient engagement strategies transforming healthcare today
The healthcare industry is rapidly shifting toward more participatory and consumer-centered medicine. This significant change in dynamics is what will push many organizations to...
Pfizer’s ‘Prevnar 20’ gets in FDA fast lane as next-gen pneumococcal...
Pfizer and Merck are both laboring away on COVID-19 vaccines, but neither has lost sight of their multibillion-dollar race for next-gen pneumococcal shots. And...
Novartis works with app maker to help eye patients ‘See What’s...
Novartis wants to help patients overcome the hurdles in specialized eye disease treatment with the help of a new digital tool.
The Swiss drugmaker worked with...
SABCS: Novartis touts Kisqali’s 5-year breast cancer survival, advantage over Pfizer’s...
Novartis already knew that adding Kisqali to endocrine therapy can help premenopausal patients with HR-positive, HER2-negative advanced breast cancer live longer. Now it knows...
Pear Therapeutics raises $80M in push for reimbursement
Pear Therapeutics raised $80 million in funding, which it plans to use as part of a push for coverage of its digital therapeutics. The...
FDA Approves Hetlioz (tasimelteon) for the Treatment of Nighttime Sleep Disturbances...
WASHINGTON, Dec. 1, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal...
South San Francisco, CA -- December 1, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...
